- Home
- CLPT vs PRQR Comparison
CLPT vs PRQR Comparison
Compare CLPT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- PRQR
- Stock Information
- Founded
- CLPT 1998
- PRQR 2012
- Country
- CLPT United States
- PRQR Netherlands
- Employees
- CLPT N/A
- PRQR N/A
- Industry
- CLPT Medical/Dental Instruments
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- PRQR Health Care
- Exchange
- CLPT Nasdaq
- PRQR Nasdaq
- Market Cap
- CLPT 337.6M
- PRQR 309.5M
- IPO Year
- CLPT N/A
- PRQR 2014
- Fundamental
- Price
- CLPT $15.75
- PRQR $2.75
- Analyst Decision
- CLPT Strong Buy
- PRQR Strong Buy
- Analyst Count
- CLPT 2
- PRQR 5
- Target Price
- CLPT $12.00
- PRQR $7.60
- AVG Volume (30 Days)
- CLPT 230.2K
- PRQR 605.4K
- Earning Date
- CLPT 11-07-2024
- PRQR 11-07-2024
- Dividend Yield
- CLPT N/A
- PRQR N/A
- EPS Growth
- CLPT N/A
- PRQR N/A
- EPS
- CLPT N/A
- PRQR N/A
- Revenue
- CLPT $30,429,000.00
- PRQR $20,506,357.00
- Revenue This Year
- CLPT $35.56
- PRQR $235.11
- Revenue Next Year
- CLPT $21.86
- PRQR N/A
- P/E Ratio
- CLPT N/A
- PRQR N/A
- Revenue Growth
- CLPT 36.34
- PRQR 306.68
- 52 Week Low
- CLPT $5.11
- PRQR $1.61
- 52 Week High
- CLPT $17.47
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- CLPT 62.00
- PRQR 37.91
- Support Level
- CLPT $14.29
- PRQR $2.48
- Resistance Level
- CLPT $16.59
- PRQR $2.83
- Average True Range (ATR)
- CLPT 1.24
- PRQR 0.28
- MACD
- CLPT 0.04
- PRQR -0.05
- Stochastic Oscillator
- CLPT 73.08
- PRQR 27.39
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.